Technetium-99m, a critical nuclear imaging radioisotope, is in short supply and could cause delays or cancellations of over 40,000 medical imaging studies daily in the United States. The global ...

Technetium, as they called it, was the last of elements 1-92 to be tracked down, and in fact it had to be synthesized rather than isolated from naturally occurring sources.

Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical ...

Technetium-99m radiopharmaceuticals will continue to have a significant impact in several areas of nuclear medicine. This publication is intended to provide a broad overview of the current status of ...

Global shortages of nuclear chemical needed for cancer scans will see patients’ appointments cancelled, minister warns ...

Cancer and heart patients in Northern Ireland are likely to have their treatment delayed or cancelled due to a “severe ...

Health Minister Mike Nesbitt said the severe UK-wide shortage of radioisotopes, used for diagnosing cancers and organ scans, ...

Technetium-99m (99mTc) is used in approximately 85% of diagnostic imaging procedures in nuclear medicine worldwide. Interruptions in the supply of molybdenum (99Mo), which is used to produce 99mTc, ...

Telix Pharmaceuticals leverages a novel theranostic approach, offering a unique risk-reward model in the challenging biotech ...

Shortages of a radioactive isotope required for diagnostic imaging and procedures, as well as some surgeries, have led to patients facing appointment cancellations throughout the UK, the Royal College ...

Verdence Capital Advisors LLC lowered its holdings in Lantheus Holdings, Inc. (NASDAQ:LNTH – Free Report) by 23.3% in the ...